What Causes Heart Palpitations in PCOS?

What Causes Heart Palpitations in PCOS?

Yes, PCOS directly causes heart palpitations in many women — primarily through insulin resistance driving sympathetic nervous system overactivation, estrogen-to-progesterone imbalance triggering cardiac excitability, and magnesium depletion lowering the threshold for arrhythmia. The main caveat: palpitations can also signal thyroid dysfunction or electrolyte abnormalities unrelated to PCOS, so an ECG and thyroid panel should always be part of the workup.

---

Why PCOS Creates the Conditions for Heart Palpitations

Polycystic ovary syndrome is a systemic endocrine disorder, not simply an ovarian one. Its hallmarks — hyperinsulinemia, androgen excess, chronic low-grade inflammation, and disrupted sex-hormone cycling — all place measurable stress on the cardiovascular system.

Insulin Resistance and Sympathetic Nervous System Activation

Approximately 65–80% of women with PCOS have insulin resistance, even those who are lean (Diamanti-Kandarakis & Dunaif, Endocrine Reviews 2012; PMID: 23065984). Chronically elevated insulin stimulates the sympathetic nervous system, raising resting heart rate and increasing the likelihood of ectopic beats — the skipped or racing sensations most people describe as palpitations.

A 2016 study published in the Journal of Clinical Endocrinology & Metabolism found that women with PCOS had significantly higher sympathetic nervous system activity compared to age- and BMI-matched controls, independent of obesity (Teede et al., JCEM 2016; PMID: 26672631). This chronic sympathetic tone is a direct pathway to palpitations.

If you've also noticed spikes in fasting glucose alongside your palpitations, it's worth reading about what causes high fasting glucose to understand how blood sugar dysregulation compounds cardiovascular symptoms.

Estrogen Dominance and Progesterone Deficiency

In PCOS, anovulatory cycles mean progesterone is often absent or low. Progesterone has a natural calming effect on cardiac tissue by modulating potassium channels in cardiomyocytes. Without sufficient progesterone to oppose it, estrogen — or more precisely, estrogen-induced catecholamine sensitivity — can make the heart more reactive.

This hormonal seesaw is the same mechanism responsible for palpitations in perimenopause and menopause, which is why PCOS and perimenopausal women often describe nearly identical symptoms despite being at different life stages.

Chronic Low-Grade Inflammation

Women with PCOS show chronically elevated CRP and inflammatory cytokines, even without diagnosable cardiovascular disease (Kelly et al., Journal of Clinical Endocrinology & Metabolism 2001; PMID: 11502785). Inflammatory mediators such as TNF-α and IL-6 directly affect cardiac ion channels, increasing ectopic beat frequency. Understanding what causes high CRP is a useful starting point if inflammation is suspected as a driver in your own labs.

Magnesium Depletion

Insulin resistance depletes intracellular magnesium because hyperinsulinemia increases renal magnesium wasting. Magnesium is essential for maintaining electrical stability in cardiac muscle — it acts as a natural calcium channel blocker. When cellular magnesium falls, calcium influx becomes dysregulated and the risk of arrhythmia and palpitations rises sharply.

A 2013 meta-analysis in PLOS ONE confirmed that low serum magnesium is independently associated with a higher incidence of arrhythmias and cardiovascular events (Del Gobbo et al., PLOS ONE 2013; PMID: 23734232). This is one reason why magnesium repletion is among the most evidence-supported interventions for palpitations in metabolic conditions.

---

What Causes Heart Palpitations in Perimenopause?

Perimenopause — the 2–10 year transition before the final menstrual period — is characterized by wildly fluctuating estrogen levels. Unlike menopause, where estrogen declines steadily, perimenopause involves erratic surges and drops. These surges transiently increase cardiac excitability through adrenergic receptor upregulation, while the drops trigger hot flashes that are themselves accompanied by sudden increases in heart rate.

For women with PCOS entering perimenopause, this hormonal turbulence is layered on top of already-dysregulated insulin signaling and androgen excess — creating a compounded risk for palpitations. Research from the SWAN study (Study of Women's Health Across the Nation) documented that palpitations peak during the late perimenopausal transition, affecting up to 54% of women in that window (Gold et al., Menopause 2004).

If lipid panels are also shifting during this period, reviewing what causes LDL particle number to be out of range can help contextualize cardiovascular risk alongside palpitation symptoms.

---

What Causes Heart Palpitations in Menopause?

At menopause (defined as 12 consecutive months without menstruation), estrogen levels stabilize at a chronically low baseline. Paradoxically, palpitations often persist because low estrogen reduces the buffering effect that estrogen previously provided on autonomic nervous system tone. The sympathovagal balance shifts toward sympathetic dominance — the same state that insulin resistance creates in PCOS.

Additionally, low estrogen accelerates bone turnover (releasing calcium), reduces magnesium absorption, and contributes to sleep fragmentation — all of which independently raise palpitation risk.

---

What Causes Heart Palpitations in Postmenopause?

In postmenopause, palpitations that persist beyond the first 1–2 years warrant closer investigation. At this stage, thyroid autoimmunity (which is more prevalent post-menopause), subclinical hyperthyroidism, and elevated homocysteine become more likely contributors. Homocysteine itself is cardiotoxic and pro-arrhythmic at elevated concentrations — you can explore what causes homocysteine to be out of range for a deeper look at this biomarker.

Postmenopausal women with a prior PCOS diagnosis also carry residual metabolic risk — their insulin resistance and androgen excess may persist independently of estrogen levels, keeping sympathetic nervous system activation elevated well into their 60s.

---

What Causes Heart Palpitations After a Hysterectomy?

A hysterectomy that preserves the ovaries (hysterectomy without oophorectomy) typically does not immediately trigger menopause, but ovarian function often declines earlier than expected — sometimes by 3–5 years — due to disrupted blood supply. The result is an earlier onset of estrogen fluctuation and its associated palpitations.

A bilateral oophorectomy (surgical menopause) causes a sudden, steep estrogen drop with no gradual transition period. This abrupt shift is more likely to cause pronounced palpitations than natural menopause because the nervous system has no time to adapt. Women who had PCOS prior to hysterectomy may find that their insulin resistance and sympathetic tone worsen after oophorectomy, compounding the cardiac symptoms.

---

Biomarkers Worth Checking

If you're experiencing palpitations in the context of PCOS (or any of the hormonal transitions above), the following labs provide actionable data:

Note: Serum magnesium is a poor proxy for intracellular magnesium. RBC magnesium testing provides a more accurate picture, and many functional practitioners prefer it.

---

Evidence-Based Strategies to Reduce Palpitations in PCOS

1. Address Insulin Resistance First

Inositol supplementation — particularly the 40:1 ratio of myo-inositol to D-chiro-inositol — has robust evidence for improving insulin sensitivity in PCOS and reducing androgen levels (Unfer et al., Gynecological Endocrinology 2017; PMID: 27808588). Berberine is another well-studied option that activates AMPK similarly to metformin.

2. Replete Magnesium

Oral magnesium glycinate is the most bioavailable and gastrointestinally tolerable form. Clinical trials have used 300–400 mg elemental magnesium daily to reduce ectopic beats and improve heart rate variability. Magnesium glycinate has better intracellular penetration than magnesium oxide, which is poorly absorbed.

3. Support Adrenal and Cortisol Balance

Chronic cortisol elevation compounds sympathetic activation. Adaptogenic herbs — particularly KSM-66 ashwagandha at 600 mg/day — have demonstrated significant cortisol reduction in randomized controlled trials (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Reduced cortisol directly lowers resting heart rate and sympathetic tone.

4. Optimize Omega-3 Fatty Acids

EPA and DHA reduce cardiac inflammation, lower triglycerides, and modestly improve heart rate variability. A 2012 Cochrane review confirmed that omega-3 supplementation reduces arrhythmia risk in multiple clinical populations. Women with PCOS tend to have elevated triglycerides — understanding what causes triglycerides to be out of range alongside palpitation symptoms offers a more complete metabolic picture.

5. Lifestyle Protocol

1. Prioritize sleep architecture — sleep deprivation elevates cortisol and increases palpitation frequency
2. Time-restricted eating — reduces postprandial insulin spikes that trigger sympathetic activation
3. Resistance training 3x/week — improves insulin sensitivity and vagal tone over 8–12 weeks
4. Reduce caffeine intake — caffeine directly increases ectopic beat frequency in sensitized individuals
5. Diaphragmatic breathing (5-5-5 pattern) — activates the vagus nerve and acutely reduces palpitation episodes

---

What This Means for Your Formula

At Ones, the AI health practitioner analyzes blood work, wearable data, and health history together — so a pattern of elevated fasting insulin, low RBC magnesium, and high resting heart rate from a wearable would all factor into a single formula recommendation.

For PCOS-related palpitations specifically, three ingredients are most likely to appear in a Ones formula:

• Magnesium Glycinate (from Magnesium Complex): Ones includes a clinical-grade magnesium complex dosed to deliver meaningful elemental magnesium — targeting the intracellular depletion that PCOS and insulin resistance drive. This directly addresses the lowered arrhythmia threshold caused by magnesium deficiency.

• KSM-66 Ashwagandha (600 mg): At the clinically validated dose used in the Chandrasekhar 2012 trial, this adaptogen reduces cortisol and sympathetic nervous system tone — the upstream driver of PCOS-related palpitations. Ones uses the KSM-66 branded extract at the full 600 mg dose, not a fractional amount.

• Omega-3 (EPA/DHA): Included at doses calibrated to your triglyceride and inflammatory marker levels, EPA and DHA address the cardiac inflammation component that amplifies palpitation frequency in women with chronic low-grade inflammation from PCOS.

Because Ones formulas are built from your actual lab results — not a generic PCOS protocol — women with normal insulin and low cortisol would receive a different combination than those with both metabolic and adrenal drivers present.

---

Key Takeaways

• Insulin resistance is the primary mechanical driver of palpitations in PCOS — it activates the sympathetic nervous system and depletes intracellular magnesium simultaneously.
• Magnesium deficiency lowers the arrhythmia threshold significantly; magnesium glycinate at 300–400 mg elemental is the most evidence-backed repletion strategy.
• Estrogen-progesterone imbalance makes palpitations worse in perimenopause, menopause, and after hysterectomy — and women with prior PCOS carry compounded risk in all three transitions.
• Key biomarkers to check include fasting insulin, RBC magnesium, hs-CRP, homocysteine, and a thyroid panel to rule out other arrhythmia drivers.
• KSM-66 ashwagandha at 600 mg/day reduces cortisol and sympathetic tone — addressing the adrenal amplification loop common in PCOS.
• Palpitations that are new, frequent, or accompanied by chest pain or syncope require immediate medical evaluation — supplements support underlying physiology but do not replace cardiac workup.